Published in Blood on March 18, 2009
Type I interferons in infectious disease. Nat Rev Immunol (2015) 2.37
Regulation of effector and memory T-cell functions by type I interferon. Immunology (2011) 1.58
The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog (2013) 1.23
IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques. Mol Ther (2010) 1.12
Lupus nephritis: the evolving role of novel therapeutics. Am J Kidney Dis (2014) 1.11
The type I interferon system in the etiopathogenesis of autoimmune diseases. Ups J Med Sci (2011) 1.10
Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection. J Exp Med (2012) 1.04
Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets. Front Immunol (2014) 1.04
IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo. Blood (2011) 1.00
Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol Mol Biol Rev (2013) 0.97
Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques. Clin Vaccine Immunol (2010) 0.94
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha. Cancer Immunol Immunother (2011) 0.92
Influenza-induced production of interferon-alpha is defective in geriatric individuals. J Clin Immunol (2010) 0.91
STAT2: A shape-shifting anti-viral super STAT. JAKSTAT (2013) 0.86
Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection. Curr Immunol Rev (2013) 0.85
Mucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity. J Immunol (2014) 0.85
IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells. J Immunol (2014) 0.83
Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions. PLoS One (2014) 0.81
Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations. J Virol (2014) 0.79
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination. Front Immunol (2016) 0.78
Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV. J Virol (2016) 0.75
STAT4-mediated transcriptional repression of the IL5 gene in human memory Th2 cells. Eur J Immunol (2016) 0.75
Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapy. J Virol (2014) 0.75
Current and Emerging Therapies for Lupus Nephritis. J Am Soc Nephrol (2016) 0.75
Sympathetic neural signaling via the β2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8(+) T-cell effector function. Eur J Immunol (2016) 0.75
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature (1999) 34.47
Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol (2003) 15.51
Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity (2007) 12.98
Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science (2002) 8.34
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol (2005) 8.27
Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol (2005) 7.74
Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science (2007) 7.64
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med (2005) 6.59
Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity (2007) 6.48
Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev (2006) 4.60
Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc Natl Acad Sci U S A (2004) 4.56
Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol (2005) 4.26
Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol (2005) 3.89
Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol (2006) 3.73
Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J Exp Med (2007) 3.67
T cell fitness determined by signal strength. Nat Immunol (2003) 3.65
Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood (2003) 3.23
Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U S A (2003) 3.23
Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol (1999) 3.10
Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med (1999) 2.98
T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood (2005) 2.95
Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med (2002) 2.89
Memory CD4 T cells emerge from effector T-cell progenitors. Nature (2008) 2.62
Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol (2007) 2.59
Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol (1996) 2.58
Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol (2006) 2.33
Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation. J Immunol (2007) 2.04
The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J Immunol (2002) 1.98
Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J Exp Med (2008) 1.94
High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. Nat Immunol (2003) 1.79
Rapid default transition of CD4 T cell effectors to functional memory cells. J Exp Med (2007) 1.69
IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFN-gamma production by CD8 T cells after Listeria monocytogenes infection. J Immunol (2007) 1.58
Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells. J Exp Med (1999) 1.52
IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype. J Immunol (2007) 1.45
Functional subsets of memory T cells identified by CCR7 expression. Curr Top Microbiol Immunol (2000) 1.39
Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo. J Immunol (1999) 1.35
T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity. J Immunol (2006) 1.31
Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progression. J Immunol (2006) 1.20
IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression. J Immunol (2007) 1.10
IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells. J Immunol (2004) 1.07
Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity. J Immunol (1994) 1.04
CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu. J Immunol (2008) 0.96
Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3. J Leukoc Biol (2006) 0.88
Brief antigenic stimulation generates effector CD8 T cells with low cytotoxic activity and high IL-2 production. J Immunol (2008) 0.85
Long-term exposure to superantigen induces p27Kip1 and Bcl-2 expression in effector memory CD4+ T cells. Cell Immunol (2007) 0.81
The specific and essential role of MAVS in antiviral innate immune responses. Immunity (2006) 6.74
Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J Exp Med (2003) 3.20
Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science (2006) 2.58
Brain responses to food logos in obese and healthy weight children. J Pediatr (2012) 1.94
2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med (2004) 1.88
Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing. Proc Natl Acad Sci U S A (2003) 1.75
Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur J Immunol (2002) 1.74
Regulation of effector and memory T-cell functions by type I interferon. Immunology (2011) 1.58
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. J Exp Med (2005) 1.44
Modulation of lymphatic muscle contractility by the neuropeptide substance P. Am J Physiol Heart Circ Physiol (2008) 1.39
Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes. J Immunol (2005) 1.39
Myogenic constriction and dilation of isolated lymphatic vessels. Am J Physiol Heart Circ Physiol (2008) 1.28
SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One (2013) 1.25
Rate-sensitive contractile responses of lymphatic vessels to circumferential stretch. J Physiol (2008) 1.21
The role of CD8 T cells in innate immunity and in antigen non-specific protection. Curr Opin Immunol (2006) 1.18
Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism. J Immunol (2011) 1.11
Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol (2010) 1.11
NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol (2004) 1.11
IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression. J Immunol (2007) 1.10
Cutting edge: The adapters EAT-2A and -2B are positive regulators of CD244- and CD84-dependent NK cell functions in the C57BL/6 mouse. J Immunol (2010) 1.07
Genetic analysis of influences on survival following Toxoplasma gondii infection. Int J Parasitol (2002) 1.04
Distinct characteristics of murine STAT4 activation in response to IL-12 and IFN-alpha. J Immunol (2006) 1.03
Pre-assembly of STAT4 with the human IFN-alpha/beta receptor-2 subunit is mediated by the STAT4 N-domain. Mol Immunol (2006) 1.01
IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo. Blood (2011) 1.00
Branding and a child's brain: an fMRI study of neural responses to logos. Soc Cogn Affect Neurosci (2012) 1.00
Interface accumulation of receptor/ligand couples in lymphocyte activation: methods, mechanisms, and significance. Immunol Rev (2002) 0.99
The role of CD94/NKG2 in innate and adaptive immunity. Immunol Res (2004) 0.99
The role of SAP and the SLAM family in autoimmunity. Curr Opin Immunol (2006) 0.98
Comparison of a family-based group intervention for youths with obesity to a brief individual family intervention: a practical clinical trial of positively fit. J Pediatr Psychol (2011) 0.98
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis. Neoplasia (2010) 0.96
2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J Immunol (2002) 0.94
Preferential survival of CD8 T and NK cells expressing high levels of CD94. J Immunol (2003) 0.94
iPhone app adherence to expert-recommended guidelines for pediatric obesity prevention. Child Obes (2014) 0.93
Transience in polarization of cytolytic effectors is required for efficient killing and controlled by Cdc42. Proc Natl Acad Sci U S A (2010) 0.93
The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression. J Immunol (2004) 0.92
Randomized trial comparing two methods of increasing dietary calcium intake in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2005) 0.92
Agonists of the follicle stimulating hormone receptor from an encoded thiazolidinone library. J Comb Chem (2004) 0.92
2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonists. J Med Chem (2008) 0.92
Frontline: absence of functional STAT4 activation despite detectable tyrosine phosphorylation induced by murine IFN-alpha. Eur J Immunol (2004) 0.92
School nurses' perceived barriers to discussing weight with children and their families: a qualitative approach. J Sch Health (2011) 0.91
Cutting edge: a T-bet-independent role for IFN-alpha/beta in regulating IL-2 secretion in human CD4+ central memory T cells. J Immunol (2008) 0.91
The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells. Eur J Immunol (2005) 0.90
IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene. J Immunol (2005) 0.89
Thymus-dependent memory phenotype CD8 T cells in naive B6.H-2Kb-/-Db-/- animals mediate an antigen-specific response against Listeria monocytogenes. J Immunol (2005) 0.88
Imatinib mesylate inhibits antigen-specific memory CD8 T cell responses in vivo. J Immunol (2007) 0.88
The protein tyrosine phosphatase PTPN4/PTP-MEG1, an enzyme capable of dephosphorylating the TCR ITAMs and regulating NF-kappaB, is dispensable for T cell development and/or T cell effector functions. Mol Immunol (2008) 0.87
Blockade of virus infection by human CD4+ T cells via a cytokine relay network. J Immunol (2008) 0.87
Ability to delay gratification and BMI in preadolescence. Obesity (Silver Spring) (2010) 0.87
STAT2: A shape-shifting anti-viral super STAT. JAKSTAT (2013) 0.86
Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo. J Immunol (2014) 0.85
Memory phenotype of CD8+ T cells in MHC class Ia-deficient mice. J Immunol (2003) 0.83
Prevalence and Health Correlates of Overweight and Obesity in Children with Autism Spectrum Disorder. J Dev Behav Pediatr (2015) 0.81
Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs. J Immunol (2004) 0.80
Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Eur J Immunol (2002) 0.79
IgE cross-linking critically impairs human monocyte function by blocking phagocytosis. J Allergy Clin Immunol (2013) 0.76
Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice. J Immunol (2006) 0.76
B6 strain Ly49I inhibitory gene expression on T cells in FVB.Ly49IB6 transgenic mice fails to prevent normal T cell functions. J Immunol (2002) 0.76
Synthesis and SAR of 2-aryloxy-4-alkoxy-pyridines as potent orally active corticotropin-releasing factor 1 receptor antagonists. J Med Chem (2008) 0.76
Tonic hyper-connectivity of reward neurocircuitry in obese children. Obesity (Silver Spring) (2014) 0.76
The status of billing and reimbursement in pediatric obesity treatment programs. J Behav Health Serv Res (2013) 0.75
Why prison instead of preschool? Arch Pediatr Adolesc Med (2007) 0.75
Introduction to the special section: rural health issues in pediatric psychology. J Pediatr Psychol (2011) 0.75
Definition of additional functional ligands for Ly49I(B6) using FVBLy49I(B6) transgenic mice and B6 natural killer cell effectors. Transplantation (2002) 0.75
Health-related quality of life in obese and overweight, treatment-seeking youth. Ethn Dis (2014) 0.75
Corrigendum: The child brain computes and utilizes internalized maternal choices. Nat Commun (2016) 0.75